Diligence memo · auto-generated · as of July 3, 2026

Helium Health

Helium Health looks over-valued against its niche peers and is dormant on financing cadence.

DeprioritizeFinancing has gone silent well past the sector's normal cadence — treat as inactive until outside confirmation of a live operation.

Businessfiled

Helium Health operates in Healthtech, based in LA, Nigeria. Africa's #1 healthcare technology provider.

Sub-sector tags: Healthcare, healthtech.

Capital & rounds (filed)filed

Helium Health has raised $10M in disclosed capital across 1 recorded round, aggregated from public filings. Its latest round is modeled as Series A (a $4.0M–$15M round).

Largest single filing: $10M on 2020-05-07.

Most recent recorded round closed around 2020-05-07.

Valuation (modeled)modeled

Provath models Helium Health at approximately $226M (range $13M–$1.2B). This is an algorithmic estimate from round sizes and same-niche peers — not a quoted or reported figure.

Read: Over-valued. Modeled value is 1.93× the median modeled value of Series A Healthtech companies in 2019–2021 (124 peers) — value vs value, same stage and era.

Financing rhythm & timingmixed

Last raise 6.2 yr ago; this sector typically re-raises about every 14 months.

Only one round on record and long silent — often defunct, acquired, or gone quiet.

Comparablesmixed

Capital scale ranks ahead of 69% of Healthtech peers (2138 compared).

Modeled value ranks above 87% of those peers.

Closest niche peers: Itamar Medical Ltd., ChartSpan Medical Technologies, Inc., 4G Clinical, LLC, Wellness Group Investors, LLC, Avation Medical, Inc..

Risks & flagsmixed

Financing has been silent well beyond sector cadence — possibly defunct, acquired, or paused.

Modeled above niche peers — valuation risk on entry.

No clearly named CEO/founder/principal in the surfaced records — key-person evidence is thin.